Stocks and Investing
Stocks and Investing
Tue, January 19, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Novak Maintained (ZYME) at Strong Buy with Increased Target to $74 on, Jan 19th, 2021
David Novak of Raymond James, Maintained "Zymeworks Inc." (ZYME) at Strong Buy with Increased Target from $60 to $74 on, Jan 19th, 2021.
David has made no other calls on ZYME in the last 4 months.
There is 1 other peer that has a rating on ZYME. Out of the 1 peers that are also analyzing ZYME, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $66 on, Tuesday, January 12th, 2021
Contributing Sources